← Evidence map

ArticleCancers2021

Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer.

Yu-Ling Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34298699